Global Lung Cancer Diagnostics Kit Market Growth 2022-2028
The global market for Lung Cancer Diagnostics Kit is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lung Cancer Diagnostics Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lung Cancer Diagnostics Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lung Cancer Diagnostics Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lung Cancer Diagnostics Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lung Cancer Diagnostics Kit players cover Swift Biosciences, Jiangsu MicroDiag Biomedicine Technology Co., Ltd, Genetic Biotek, Asuragen and Fujirebio, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lung Cancer Diagnostics Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lung Cancer Diagnostics Kit market, with both quantitative and qualitative data, to help readers understand how the Lung Cancer Diagnostics Kit market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Lung Cancer Diagnostics Kit market and forecasts the market size by Type (Non-Small Cell Lung Cancer and Small Cell Lung Cancer,), by Application (Hospitals and Cancer Research Centers.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Segmentation by application
Hospitals
Cancer Research Centers
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Swift Biosciences
Jiangsu MicroDiag Biomedicine Technology Co., Ltd
Genetic Biotek
Asuragen
Fujirebio
IDL Biotech
LCM Genect srl
Panagene Inc.
ViennaLab Diagnostics
Xian Tianlong Science and Technology Co.,Ltd
Jiangsu Mole Bioscience
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Gencurix
HTG Molecular
Beijing ACCB Biotech Ltd.
Chapter Introduction
Chapter 1: Scope of Lung Cancer Diagnostics Kit, Research Methodology, etc.
Chapter 2: Executive Summary, global Lung Cancer Diagnostics Kit market size (sales and revenue) and CAGR, Lung Cancer Diagnostics Kit market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lung Cancer Diagnostics Kit sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lung Cancer Diagnostics Kit sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lung Cancer Diagnostics Kit market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Swift Biosciences, Jiangsu MicroDiag Biomedicine Technology Co., Ltd, Genetic Biotek, Asuragen, Fujirebio, IDL Biotech, LCM Genect srl, Panagene Inc. and ViennaLab Diagnostics, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Diagnostics Kit Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lung Cancer Diagnostics Kit by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lung Cancer Diagnostics Kit by Country/Region, 2017, 2022 & 2028
2.2 Lung Cancer Diagnostics Kit Segment by Type
2.2.1 Non-Small Cell Lung Cancer
2.2.2 Small Cell Lung Cancer
2.3 Lung Cancer Diagnostics Kit Sales by Type
2.3.1 Global Lung Cancer Diagnostics Kit Sales Market Share by Type (2017-2022)
2.3.2 Global Lung Cancer Diagnostics Kit Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lung Cancer Diagnostics Kit Sale Price by Type (2017-2022)
2.4 Lung Cancer Diagnostics Kit Segment by Application
2.4.1 Hospitals
2.4.2 Cancer Research Centers
2.5 Lung Cancer Diagnostics Kit Sales by Application
2.5.1 Global Lung Cancer Diagnostics Kit Sale Market Share by Application (2017-2022)
2.5.2 Global Lung Cancer Diagnostics Kit Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lung Cancer Diagnostics Kit Sale Price by Application (2017-2022)
3 Global Lung Cancer Diagnostics Kit by Company
3.1 Global Lung Cancer Diagnostics Kit Breakdown Data by Company
3.1.1 Global Lung Cancer Diagnostics Kit Annual Sales by Company (2020-2022)
3.1.2 Global Lung Cancer Diagnostics Kit Sales Market Share by Company (2020-2022)
3.2 Global Lung Cancer Diagnostics Kit Annual Revenue by Company (2020-2022)
3.2.1 Global Lung Cancer Diagnostics Kit Revenue by Company (2020-2022)
3.2.2 Global Lung Cancer Diagnostics Kit Revenue Market Share by Company (2020-2022)
3.3 Global Lung Cancer Diagnostics Kit Sale Price by Company
3.4 Key Manufacturers Lung Cancer Diagnostics Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lung Cancer Diagnostics Kit Product Location Distribution
3.4.2 Players Lung Cancer Diagnostics Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lung Cancer Diagnostics Kit by Geographic Region
4.1 World Historic Lung Cancer Diagnostics Kit Market Size by Geographic Region (2017-2022)
4.1.1 Global Lung Cancer Diagnostics Kit Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lung Cancer Diagnostics Kit Annual Revenue by Geographic Region
4.2 World Historic Lung Cancer Diagnostics Kit Market Size by Country/Region (2017-2022)
4.2.1 Global Lung Cancer Diagnostics Kit Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lung Cancer Diagnostics Kit Annual Revenue by Country/Region
4.3 Americas Lung Cancer Diagnostics Kit Sales Growth
4.4 APAC Lung Cancer Diagnostics Kit Sales Growth
4.5 Europe Lung Cancer Diagnostics Kit Sales Growth
4.6 Middle East & Africa Lung Cancer Diagnostics Kit Sales Growth
5 Americas
5.1 Americas Lung Cancer Diagnostics Kit Sales by Country
5.1.1 Americas Lung Cancer Diagnostics Kit Sales by Country (2017-2022)
5.1.2 Americas Lung Cancer Diagnostics Kit Revenue by Country (2017-2022)
5.2 Americas Lung Cancer Diagnostics Kit Sales by Type
5.3 Americas Lung Cancer Diagnostics Kit Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Diagnostics Kit Sales by Region
6.1.1 APAC Lung Cancer Diagnostics Kit Sales by Region (2017-2022)
6.1.2 APAC Lung Cancer Diagnostics Kit Revenue by Region (2017-2022)
6.2 APAC Lung Cancer Diagnostics Kit Sales by Type
6.3 APAC Lung Cancer Diagnostics Kit Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lung Cancer Diagnostics Kit by Country
7.1.1 Europe Lung Cancer Diagnostics Kit Sales by Country (2017-2022)
7.1.2 Europe Lung Cancer Diagnostics Kit Revenue by Country (2017-2022)
7.2 Europe Lung Cancer Diagnostics Kit Sales by Type
7.3 Europe Lung Cancer Diagnostics Kit Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer Diagnostics Kit by Country
8.1.1 Middle East & Africa Lung Cancer Diagnostics Kit Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lung Cancer Diagnostics Kit Revenue by Country (2017-2022)
8.2 Middle East & Africa Lung Cancer Diagnostics Kit Sales by Type
8.3 Middle East & Africa Lung Cancer Diagnostics Kit Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Cancer Diagnostics Kit
10.3 Manufacturing Process Analysis of Lung Cancer Diagnostics Kit
10.4 Industry Chain Structure of Lung Cancer Diagnostics Kit
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lung Cancer Diagnostics Kit Distributors
11.3 Lung Cancer Diagnostics Kit Customer
12 World Forecast Review for Lung Cancer Diagnostics Kit by Geographic Region
12.1 Global Lung Cancer Diagnostics Kit Market Size Forecast by Region
12.1.1 Global Lung Cancer Diagnostics Kit Forecast by Region (2023-2028)
12.1.2 Global Lung Cancer Diagnostics Kit Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lung Cancer Diagnostics Kit Forecast by Type
12.7 Global Lung Cancer Diagnostics Kit Forecast by Application
13 Key Players Analysis
13.1 Swift Biosciences
13.1.1 Swift Biosciences Company Information
13.1.2 Swift Biosciences Lung Cancer Diagnostics Kit Product Offered
13.1.3 Swift Biosciences Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Swift Biosciences Main Business Overview
13.1.5 Swift Biosciences Latest Developments
13.2 Jiangsu MicroDiag Biomedicine Technology Co., Ltd
13.2.1 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Company Information
13.2.2 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Product Offered
13.2.3 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Main Business Overview
13.2.5 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Latest Developments
13.3 Genetic Biotek
13.3.1 Genetic Biotek Company Information
13.3.2 Genetic Biotek Lung Cancer Diagnostics Kit Product Offered
13.3.3 Genetic Biotek Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Genetic Biotek Main Business Overview
13.3.5 Genetic Biotek Latest Developments
13.4 Asuragen
13.4.1 Asuragen Company Information
13.4.2 Asuragen Lung Cancer Diagnostics Kit Product Offered
13.4.3 Asuragen Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Asuragen Main Business Overview
13.4.5 Asuragen Latest Developments
13.5 Fujirebio
13.5.1 Fujirebio Company Information
13.5.2 Fujirebio Lung Cancer Diagnostics Kit Product Offered
13.5.3 Fujirebio Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Fujirebio Main Business Overview
13.5.5 Fujirebio Latest Developments
13.6 IDL Biotech
13.6.1 IDL Biotech Company Information
13.6.2 IDL Biotech Lung Cancer Diagnostics Kit Product Offered
13.6.3 IDL Biotech Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 IDL Biotech Main Business Overview
13.6.5 IDL Biotech Latest Developments
13.7 LCM Genect srl
13.7.1 LCM Genect srl Company Information
13.7.2 LCM Genect srl Lung Cancer Diagnostics Kit Product Offered
13.7.3 LCM Genect srl Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 LCM Genect srl Main Business Overview
13.7.5 LCM Genect srl Latest Developments
13.8 Panagene Inc.
13.8.1 Panagene Inc. Company Information
13.8.2 Panagene Inc. Lung Cancer Diagnostics Kit Product Offered
13.8.3 Panagene Inc. Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Panagene Inc. Main Business Overview
13.8.5 Panagene Inc. Latest Developments
13.9 ViennaLab Diagnostics
13.9.1 ViennaLab Diagnostics Company Information
13.9.2 ViennaLab Diagnostics Lung Cancer Diagnostics Kit Product Offered
13.9.3 ViennaLab Diagnostics Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ViennaLab Diagnostics Main Business Overview
13.9.5 ViennaLab Diagnostics Latest Developments
13.10 Xian Tianlong Science and Technology Co.,Ltd
13.10.1 Xian Tianlong Science and Technology Co.,Ltd Company Information
13.10.2 Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Product Offered
13.10.3 Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Xian Tianlong Science and Technology Co.,Ltd Main Business Overview
13.10.5 Xian Tianlong Science and Technology Co.,Ltd Latest Developments
13.11 Jiangsu Mole Bioscience
13.11.1 Jiangsu Mole Bioscience Company Information
13.11.2 Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Product Offered
13.11.3 Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jiangsu Mole Bioscience Main Business Overview
13.11.5 Jiangsu Mole Bioscience Latest Developments
13.12 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
13.12.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
13.12.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Product Offered
13.12.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Main Business Overview
13.12.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Latest Developments
13.13 Gencurix
13.13.1 Gencurix Company Information
13.13.2 Gencurix Lung Cancer Diagnostics Kit Product Offered
13.13.3 Gencurix Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Gencurix Main Business Overview
13.13.5 Gencurix Latest Developments
13.14 HTG Molecular
13.14.1 HTG Molecular Company Information
13.14.2 HTG Molecular Lung Cancer Diagnostics Kit Product Offered
13.14.3 HTG Molecular Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 HTG Molecular Main Business Overview
13.14.5 HTG Molecular Latest Developments
13.15 Beijing ACCB Biotech Ltd.
13.15.1 Beijing ACCB Biotech Ltd. Company Information
13.15.2 Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Product Offered
13.15.3 Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Beijing ACCB Biotech Ltd. Main Business Overview
13.15.5 Beijing ACCB Biotech Ltd. Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Lung Cancer Diagnostics Kit Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lung Cancer Diagnostics Kit Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Non-Small Cell Lung Cancer
Table 4. Major Players of Small Cell Lung Cancer
Table 5. Global Lung Cancer Diagnostics Kit Sales by Type (2017-2022) & (K Units)
Table 6. Global Lung Cancer Diagnostics Kit Sales Market Share by Type (2017-2022)
Table 7. Global Lung Cancer Diagnostics Kit Revenue by Type (2017-2022) & ($ million)
Table 8. Global Lung Cancer Diagnostics Kit Revenue Market Share by Type (2017-2022)
Table 9. Global Lung Cancer Diagnostics Kit Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Lung Cancer Diagnostics Kit Sales by Application (2017-2022) & (K Units)
Table 11. Global Lung Cancer Diagnostics Kit Sales Market Share by Application (2017-2022)
Table 12. Global Lung Cancer Diagnostics Kit Revenue by Application (2017-2022)
Table 13. Global Lung Cancer Diagnostics Kit Revenue Market Share by Application (2017-2022)
Table 14. Global Lung Cancer Diagnostics Kit Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Lung Cancer Diagnostics Kit Sales by Company (2020-2022) & (K Units)
Table 16. Global Lung Cancer Diagnostics Kit Sales Market Share by Company (2020-2022)
Table 17. Global Lung Cancer Diagnostics Kit Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Lung Cancer Diagnostics Kit Revenue Market Share by Company (2020-2022)
Table 19. Global Lung Cancer Diagnostics Kit Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Lung Cancer Diagnostics Kit Producing Area Distribution and Sales Area
Table 21. Players Lung Cancer Diagnostics Kit Products Offered
Table 22. Lung Cancer Diagnostics Kit Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lung Cancer Diagnostics Kit Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Lung Cancer Diagnostics Kit Sales Market Share Geographic Region (2017-2022)
Table 27. Global Lung Cancer Diagnostics Kit Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Lung Cancer Diagnostics Kit Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Lung Cancer Diagnostics Kit Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Lung Cancer Diagnostics Kit Sales Market Share by Country/Region (2017-2022)
Table 31. Global Lung Cancer Diagnostics Kit Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Lung Cancer Diagnostics Kit Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Lung Cancer Diagnostics Kit Sales by Country (2017-2022) & (K Units)
Table 34. Americas Lung Cancer Diagnostics Kit Sales Market Share by Country (2017-2022)
Table 35. Americas Lung Cancer Diagnostics Kit Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Lung Cancer Diagnostics Kit Revenue Market Share by Country (2017-2022)
Table 37. Americas Lung Cancer Diagnostics Kit Sales by Type (2017-2022) & (K Units)
Table 38. Americas Lung Cancer Diagnostics Kit Sales Market Share by Type (2017-2022)
Table 39. Americas Lung Cancer Diagnostics Kit Sales by Application (2017-2022) & (K Units)
Table 40. Americas Lung Cancer Diagnostics Kit Sales Market Share by Application (2017-2022)
Table 41. APAC Lung Cancer Diagnostics Kit Sales by Region (2017-2022) & (K Units)
Table 42. APAC Lung Cancer Diagnostics Kit Sales Market Share by Region (2017-2022)
Table 43. APAC Lung Cancer Diagnostics Kit Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Lung Cancer Diagnostics Kit Revenue Market Share by Region (2017-2022)
Table 45. APAC Lung Cancer Diagnostics Kit Sales by Type (2017-2022) & (K Units)
Table 46. APAC Lung Cancer Diagnostics Kit Sales Market Share by Type (2017-2022)
Table 47. APAC Lung Cancer Diagnostics Kit Sales by Application (2017-2022) & (K Units)
Table 48. APAC Lung Cancer Diagnostics Kit Sales Market Share by Application (2017-2022)
Table 49. Europe Lung Cancer Diagnostics Kit Sales by Country (2017-2022) & (K Units)
Table 50. Europe Lung Cancer Diagnostics Kit Sales Market Share by Country (2017-2022)
Table 51. Europe Lung Cancer Diagnostics Kit Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Lung Cancer Diagnostics Kit Revenue Market Share by Country (2017-2022)
Table 53. Europe Lung Cancer Diagnostics Kit Sales by Type (2017-2022) & (K Units)
Table 54. Europe Lung Cancer Diagnostics Kit Sales Market Share by Type (2017-2022)
Table 55. Europe Lung Cancer Diagnostics Kit Sales by Application (2017-2022) & (K Units)
Table 56. Europe Lung Cancer Diagnostics Kit Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Lung Cancer Diagnostics Kit Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Lung Cancer Diagnostics Kit Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Lung Cancer Diagnostics Kit Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Lung Cancer Diagnostics Kit Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Lung Cancer Diagnostics Kit Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Lung Cancer Diagnostics Kit Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Lung Cancer Diagnostics Kit Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Lung Cancer Diagnostics Kit Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Lung Cancer Diagnostics Kit
Table 66. Key Market Challenges & Risks of Lung Cancer Diagnostics Kit
Table 67. Key Industry Trends of Lung Cancer Diagnostics Kit
Table 68. Lung Cancer Diagnostics Kit Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Lung Cancer Diagnostics Kit Distributors List
Table 71. Lung Cancer Diagnostics Kit Customer List
Table 72. Global Lung Cancer Diagnostics Kit Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Lung Cancer Diagnostics Kit Sales Market Forecast by Region
Table 74. Global Lung Cancer Diagnostics Kit Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Lung Cancer Diagnostics Kit Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Lung Cancer Diagnostics Kit Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Lung Cancer Diagnostics Kit Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Lung Cancer Diagnostics Kit Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Lung Cancer Diagnostics Kit Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Lung Cancer Diagnostics Kit Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Lung Cancer Diagnostics Kit Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Lung Cancer Diagnostics Kit Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Lung Cancer Diagnostics Kit Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Lung Cancer Diagnostics Kit Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Lung Cancer Diagnostics Kit Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Lung Cancer Diagnostics Kit Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Lung Cancer Diagnostics Kit Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Lung Cancer Diagnostics Kit Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Lung Cancer Diagnostics Kit Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Lung Cancer Diagnostics Kit Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Lung Cancer Diagnostics Kit Revenue Market Share Forecast by Application (2023-2028)
Table 92. Swift Biosciences Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 93. Swift Biosciences Lung Cancer Diagnostics Kit Product Offered
Table 94. Swift Biosciences Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Swift Biosciences Main Business
Table 96. Swift Biosciences Latest Developments
Table 97. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Product Offered
Table 99. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Main Business
Table 101. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Latest Developments
Table 102. Genetic Biotek Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 103. Genetic Biotek Lung Cancer Diagnostics Kit Product Offered
Table 104. Genetic Biotek Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Genetic Biotek Main Business
Table 106. Genetic Biotek Latest Developments
Table 107. Asuragen Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 108. Asuragen Lung Cancer Diagnostics Kit Product Offered
Table 109. Asuragen Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Asuragen Main Business
Table 111. Asuragen Latest Developments
Table 112. Fujirebio Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 113. Fujirebio Lung Cancer Diagnostics Kit Product Offered
Table 114. Fujirebio Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Fujirebio Main Business
Table 116. Fujirebio Latest Developments
Table 117. IDL Biotech Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 118. IDL Biotech Lung Cancer Diagnostics Kit Product Offered
Table 119. IDL Biotech Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. IDL Biotech Main Business
Table 121. IDL Biotech Latest Developments
Table 122. LCM Genect srl Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 123. LCM Genect srl Lung Cancer Diagnostics Kit Product Offered
Table 124. LCM Genect srl Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. LCM Genect srl Main Business
Table 126. LCM Genect srl Latest Developments
Table 127. Panagene Inc. Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 128. Panagene Inc. Lung Cancer Diagnostics Kit Product Offered
Table 129. Panagene Inc. Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Panagene Inc. Main Business
Table 131. Panagene Inc. Latest Developments
Table 132. ViennaLab Diagnostics Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 133. ViennaLab Diagnostics Lung Cancer Diagnostics Kit Product Offered
Table 134. ViennaLab Diagnostics Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. ViennaLab Diagnostics Main Business
Table 136. ViennaLab Diagnostics Latest Developments
Table 137. Xian Tianlong Science and Technology Co.,Ltd Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 138. Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Product Offered
Table 139. Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Xian Tianlong Science and Technology Co.,Ltd Main Business
Table 141. Xian Tianlong Science and Technology Co.,Ltd Latest Developments
Table 142. Jiangsu Mole Bioscience Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Product Offered
Table 144. Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Jiangsu Mole Bioscience Main Business
Table 146. Jiangsu Mole Bioscience Latest Developments
Table 147. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Product Offered
Table 149. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Main Business
Table 151. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Latest Developments
Table 152. Gencurix Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 153. Gencurix Lung Cancer Diagnostics Kit Product Offered
Table 154. Gencurix Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Gencurix Main Business
Table 156. Gencurix Latest Developments
Table 157. HTG Molecular Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 158. HTG Molecular Lung Cancer Diagnostics Kit Product Offered
Table 159. HTG Molecular Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. HTG Molecular Main Business
Table 161. HTG Molecular Latest Developments
Table 162. Beijing ACCB Biotech Ltd. Basic Information, Lung Cancer Diagnostics Kit Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Product Offered
Table 164. Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Beijing ACCB Biotech Ltd. Main Business
Table 166. Beijing ACCB Biotech Ltd. Latest Developments
List of Figures
Figure 1. Picture of Lung Cancer Diagnostics Kit
Figure 2. Lung Cancer Diagnostics Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Cancer Diagnostics Kit Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Lung Cancer Diagnostics Kit Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lung Cancer Diagnostics Kit Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Non-Small Cell Lung Cancer
Figure 10. Product Picture of Small Cell Lung Cancer
Figure 11. Global Lung Cancer Diagnostics Kit Sales Market Share by Type in 2021
Figure 12. Global Lung Cancer Diagnostics Kit Revenue Market Share by Type (2017-2022)
Figure 13. Lung Cancer Diagnostics Kit Consumed in Hospitals
Figure 14. Global Lung Cancer Diagnostics Kit Market: Hospitals (2017-2022) & (K Units)
Figure 15. Lung Cancer Diagnostics Kit Consumed in Cancer Research Centers
Figure 16. Global Lung Cancer Diagnostics Kit Market: Cancer Research Centers (2017-2022) & (K Units)
Figure 17. Global Lung Cancer Diagnostics Kit Sales Market Share by Application (2017-2022)
Figure 18. Global Lung Cancer Diagnostics Kit Revenue Market Share by Application in 2021
Figure 19. Lung Cancer Diagnostics Kit Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Lung Cancer Diagnostics Kit Revenue Market Share by Company in 2021
Figure 21. Global Lung Cancer Diagnostics Kit Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Lung Cancer Diagnostics Kit Revenue Market Share by Geographic Region in 2021
Figure 23. Global Lung Cancer Diagnostics Kit Sales Market Share by Region (2017-2022)
Figure 24. Global Lung Cancer Diagnostics Kit Revenue Market Share by Country/Region in 2021
Figure 25. Americas Lung Cancer Diagnostics Kit Sales 2017-2022 (K Units)
Figure 26. Americas Lung Cancer Diagnostics Kit Revenue 2017-2022 ($ Millions)
Figure 27. APAC Lung Cancer Diagnostics Kit Sales 2017-2022 (K Units)
Figure 28. APAC Lung Cancer Diagnostics Kit Revenue 2017-2022 ($ Millions)
Figure 29. Europe Lung Cancer Diagnostics Kit Sales 2017-2022 (K Units)
Figure 30. Europe Lung Cancer Diagnostics Kit Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Lung Cancer Diagnostics Kit Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Lung Cancer Diagnostics Kit Revenue 2017-2022 ($ Millions)
Figure 33. Americas Lung Cancer Diagnostics Kit Sales Market Share by Country in 2021
Figure 34. Americas Lung Cancer Diagnostics Kit Revenue Market Share by Country in 2021
Figure 35. United States Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Lung Cancer Diagnostics Kit Sales Market Share by Region in 2021
Figure 40. APAC Lung Cancer Diagnostics Kit Revenue Market Share by Regions in 2021
Figure 41. China Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Lung Cancer Diagnostics Kit Sales Market Share by Country in 2021
Figure 48. Europe Lung Cancer Diagnostics Kit Revenue Market Share by Country in 2021
Figure 49. Germany Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Lung Cancer Diagnostics Kit Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Lung Cancer Diagnostics Kit Revenue Market Share by Country in 2021
Figure 56. Egypt Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Lung Cancer Diagnostics Kit Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Lung Cancer Diagnostics Kit in 2021
Figure 62. Manufacturing Process Analysis of Lung Cancer Diagnostics Kit
Figure 63. Industry Chain Structure of Lung Cancer Diagnostics Kit
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets